tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

AKRO Stock Latest News

89bio initiated with an Outperform at Wolfe Research
The Fly89bio initiated with an Outperform at Wolfe Research
11h ago
AKRO
ETNB
89bio price target raised to $38 from $25 at UBS, says shares ‘undervalued’
PremiumThe Fly
89bio price target raised to $38 from $25 at UBS, says shares ‘undervalued’
4d ago
AKRO
ETNB
Akero Therapeutics price target raised to $109 from $42 at UBS
PremiumThe Fly
Akero Therapeutics price target raised to $109 from $42 at UBS
4d ago
AKRO
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5d ago
AKRO
ALLK
Akero upgraded to Buy at BofA after ‘transformative’ liver data
PremiumThe Fly
Akero upgraded to Buy at BofA after ‘transformative’ liver data
5d ago
AKRO
ETNB
Akero Therapeutics upgraded to Buy from Neutral at BofA
PremiumThe FlyAkero Therapeutics upgraded to Buy from Neutral at BofA
5d ago
AKRO
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6d ago
AKRO
ALLK
Akero Therapeutics 5.333M share Secondary priced at $48.00
Premium
The Fly
Akero Therapeutics 5.333M share Secondary priced at $48.00
6d ago
AKRO
Akero Therapeutics price target raised to $96 from $46 at Morgan Stanley
PremiumThe Fly
Akero Therapeutics price target raised to $96 from $46 at Morgan Stanley
7d ago
AKRO
Akero Therapeutics price target raised to $73 from $56 at Canaccord
PremiumThe Fly
Akero Therapeutics price target raised to $73 from $56 at Canaccord
7d ago
AKRO
Akero Shares Skyrocket as MASH Drug Delivers Game-Changing Results
PremiumMarket News
Akero Shares Skyrocket as MASH Drug Delivers Game-Changing Results
7d ago
LLY
AKRO
Akero Therapeutics price target raised to $80 from $65 at Citi
PremiumThe Fly
Akero Therapeutics price target raised to $80 from $65 at Citi
7d ago
AKRO
Akero Therapeutics announces $300M common stock offering
PremiumThe FlyAkero Therapeutics announces $300M common stock offering
8d ago
AKRO
Madrigal dip on Akero data a buying opportunity, says Evercore ISI
Premium
The Fly
Madrigal dip on Akero data a buying opportunity, says Evercore ISI
8d ago
AKRO
MDGL
China’s DeepSeek sinks tech, AT&T reports Q4 beat: Morning Buzz
Premium
The Fly
China’s DeepSeek sinks tech, AT&T reports Q4 beat: Morning Buzz
8d ago
T
JD
H.C. Wainwright ups Akero target after ‘ground-breaking’ data
PremiumThe Fly
H.C. Wainwright ups Akero target after ‘ground-breaking’ data
8d ago
AKRO
H.C. Wainwright upgrades Akero target after ‘ground-breaking’ data
PremiumThe Fly
H.C. Wainwright upgrades Akero target after ‘ground-breaking’ data
8d ago
AKRO
Akero Therapeutics Reports Promising Phase 2b Study Results
PremiumCompany Announcements
Akero Therapeutics Reports Promising Phase 2b Study Results
8d ago
8K
AKRO
Akero Therapeutics MASH data ‘best-case-scenario,’ says Citi
PremiumThe Fly
Akero Therapeutics MASH data ‘best-case-scenario,’ says Citi
8d ago
AKRO
Akero Therapeutics’ efruxifermin shows efficacy in Phase 2b cirrhosis trial
PremiumThe FlyAkero Therapeutics’ efruxifermin shows efficacy in Phase 2b cirrhosis trial
8d ago
AKRO
Akero completes enrollment of double-blind portion in SYNCHRONY study
Premium
The Fly
Akero completes enrollment of double-blind portion in SYNCHRONY study
22d ago
AKRO
Roku, Robinhood upgraded: Wall Street’s top analyst calls
Premium
The Fly
Roku, Robinhood upgraded: Wall Street’s top analyst calls
3M ago
CR
EOG

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >